TY - JOUR
T1 - National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand
T2 - Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
AU - NHFA CSANZ Atrial Fibrillation Guideline Working Group
AU - Brieger, David
AU - Amerena, John
AU - Attia, John
AU - Bajorek, Beata
AU - Chan, Kim H.
AU - Connell, Cia
AU - Freedman, Ben
AU - Ferguson, Caleb
AU - Hall, Tanya
AU - Haqqani, Haris
AU - Hendriks, Jeroen
AU - Hespe, Charlotte
AU - Hung, Joseph
AU - Kalman, Jonathan M.
AU - Sanders, Prashanthan
AU - Worthington, John
AU - Yan, Tristan D.
AU - Zwar, Nicholas
N1 - Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
This is a human-readable summary of (and not a substitute for) the license. Disclaimer You are free to:
Share — copy and redistribute the material in any medium or format
The licensor cannot revoke these freedoms as long as you follow the license terms.
PY - 2018/10
Y1 - 2018/10
N2 - In 2015, the National Heart Foundation of Australia (NHFA) and the Cardiac Society of Australia and New Zealand (CSANZ) undertook a survey of emerging issues in cardiovascular disease. The goal was to prioritise clinical conditions that would benefit from locally developed contemporary guidelines. Individual diseases were evaluated according to burden of disease, the existence of treatment gaps, an evolving therapeutic landscape, evidence of inequity and the existence of local treatment guidelines. Atrial fibrillation (AF) scored highly in each of these categories. Specifically, AF was recognised as a burdensome condition with increasing prevalence, where large numbers of patients are not treated with anticoagulation, despite the clear benefit of this therapy in stroke prevention.
AB - In 2015, the National Heart Foundation of Australia (NHFA) and the Cardiac Society of Australia and New Zealand (CSANZ) undertook a survey of emerging issues in cardiovascular disease. The goal was to prioritise clinical conditions that would benefit from locally developed contemporary guidelines. Individual diseases were evaluated according to burden of disease, the existence of treatment gaps, an evolving therapeutic landscape, evidence of inequity and the existence of local treatment guidelines. Atrial fibrillation (AF) scored highly in each of these categories. Specifically, AF was recognised as a burdensome condition with increasing prevalence, where large numbers of patients are not treated with anticoagulation, despite the clear benefit of this therapy in stroke prevention.
KW - Atrial Fibrillation
KW - National Heart Foundation -Australia
KW - Guidelines
KW - Diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85050126961&partnerID=8YFLogxK
U2 - 10.1016/j.hlc.2018.06.1043
DO - 10.1016/j.hlc.2018.06.1043
M3 - Article
C2 - 30077228
AN - SCOPUS:85050126961
VL - 27
SP - 1209
EP - 1266
JO - Heart, Lung and Circulation
JF - Heart, Lung and Circulation
SN - 1443-9506
IS - 10
ER -